Over the years, seniors often experience limitations in their walking ability. These limitations can indicate diseases that are not initially associated with gait disorders. Scientists from France and Canada have now confirmed that gait performance provides „valuable insights“ into the cognitive functions of older people...
What is the risk of an older person developing dementia after a fall? Researchers from the USA found: In 10.6 percent of patients treated for a fall, dementia was diagnosed within one year. Previous studies have already shown a connection between mild cognitive...
In the sixth edition of our special newsletter SCHLAGLICHT – New Medications Against Dementia, Lisa Laininger, research associate at digiDEM Bayern, discusses the publication by Dr. Jeffrey L. Cummings of the University of Nevada Las Vegas and his colleagues, titled Lecanemab: Appropriate Use Recommendations, in the professional journal The Journal of Prevention of Alzheimer’s…
To what extent are mobile health (mHealth) interventions on smartphones, supported by a coach, suitable for reducing dementia risk? Researchers investigated this with a focus on individuals aged 55 to 75 who had a high risk of dementia. The study included, on the one hand, population groups from Great Britain with a low socioeconomic status, and on the other hand, the general population in the greater area of...
In the fifth edition of our special newsletter, SCHLAGLICHT – New Drugs for Dementia, Anne Keefer, a research associate at digiDEM Bayern, discusses the publication by an international group of researchers led by Prof. Alberto J. Espay of the University of Cincinnati. In the article titled "Recalibrating the Risk-Benefit Profiles of Lecanemab..."
The risk of developing Alzheimer's dementia is higher for people with mild cognitive impairment (MCI). But to what extent is it possible to predict the progression to Alzheimer's dementia at all? Why can this be an important factor? An accurate prediction could help doctors in their decision-making regarding treatment of...
In the fourth edition of our new special newsletter SCHLAGLICHT – New Drugs for Dementia, Florian Weidinger, research associate at digiDEM Bayern, deals with the publication "The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer’s disease: an EADC-EC viewpoint" by the research team led by Professor Linus Jönsson from the Karolinska Institutet in Sweden. In the journal The Lancet…
In the third issue of our new special newsletter "SCHLAGLICHT – New Medications for Dementia," Dr. Nikolas Dietzel, a research associate at digiDEM Bayern, discusses the publication by scientists from Europe, the USA, and Australia, led by Professor Poul F. Høilund-Carlsen from Odense University Hospital in Denmark. In the article titled "Donanemab, another anti-Alzheimer’s…"
Dementias can be associated with an increased urge to move, which can pose certain dangers. When people with cognitive impairments leave their homes and wander outdoors, their risk of fractures or other injuries increases. This is a very worrying situation for caregivers. To what extent the still young technology...
Sleep deprivation has long been recognized as a significant problem. Researchers from the USA have demonstrated why older women, in particular, should pay attention to getting enough sleep. This is because sleep duration predicts future risk for cognitive impairment, including dementia. Did you know that the first experimental study on sleep deprivation in humans was conducted in 1896…
